News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Insightful Corporation (IFUL) Announces S+ArrayAnalyzer 2.1; Rigorous Statistical Analysis Software Now Scales To Large Array Experiments Improving Drug Discovery Accuracy For Growing DNA Microarray Market



10/19/2005 5:13:15 PM

SEATTLE--(BUSINESS WIRE)--April 11, 2005--Insightful Corporation (Nasdaq:IFUL), a leading provider of software solutions for analysis of numeric and text data, announced today concurrently with S-PLUS(R) 7, the launch of S+ArrayAnalyzer(R) 2.1, a statistically-robust and highly-adaptable microarray analysis software product designed to enable powerful yet simple analyses of complex microarray data. In combination with the new S-PLUS 7 scalability improvements, S+ArrayAnalyzer now comfortably handles differential expression and class discovery/prediction analyses of large high-throughput microarray experiments. Microarrays are a revolutionary and fast-growing assay technology in the pharmaceutical industry that enable an understanding of the interactions between gene expression, disease pathways, and drug response. Statistical analysis of microarray experiments is crucial in many applications, including identifying and evaluating new drugs, developing biomarkers and diagnostics, classifying diseases, and creating personalized patient treatment plans.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES